S

S2Medical AB (publ)
STO:S2M

Watchlist Manager
S2Medical AB (publ)
STO:S2M
Watchlist
Price: 0.011 SEK Market Closed
Market Cap: 10.8m SEK
Have any thoughts about
S2Medical AB (publ)?
Write Note

S2Medical AB (publ)
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

S2Medical AB (publ)
Capital Expenditures Peer Comparison

Comparables:
O
OSSD
XVIVO
D
DOXA
BACTI B
V
VIMIAN

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
S
S2Medical AB (publ)
STO:S2M
Capital Expenditures
-kr1.1m
CAGR 3-Years
28%
CAGR 5-Years
21%
CAGR 10-Years
N/A
O
OssDsign AB
STO:OSSD
Capital Expenditures
-kr124k
CAGR 3-Years
63%
CAGR 5-Years
56%
CAGR 10-Years
N/A
Xvivo Perfusion AB
STO:XVIVO
Capital Expenditures
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
D
Doxa AB
STO:DOXA
Capital Expenditures
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bactiguard Holding AB
STO:BACTI B
Capital Expenditures
-kr8.6m
CAGR 3-Years
18%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
V
Vimian Group AB
STO:VIMIAN
Capital Expenditures
-€14.6m
CAGR 3-Years
-14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is S2Medical AB (publ)'s Capital Expenditures?
Capital Expenditures
-1.1m SEK

Based on the financial report for Jun 30, 2024, S2Medical AB (publ)'s Capital Expenditures amounts to -1.1m SEK.

What is S2Medical AB (publ)'s Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
21%

Over the last year, the Capital Expenditures growth was 14%. The average annual Capital Expenditures growth rates for S2Medical AB (publ) have been 28% over the past three years , 21% over the past five years .

Back to Top